Gadodiamide

This classification denotes a gadolinium-chelate with the molecular formula C16H26GdN5O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 84F6U3J2R6, chemically known as gadolinium, aqua(5,8-bis(carboxymethyl)-11-(2-(methylamino)-2-oxoethyl)-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-))-, hydrate but more generally known as gadodiamide, which bears U.S. National Institutes of Health Compound Identifier 60754. The European Medicines Agency schedules Gadodiamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07862MIG. The term GADODIAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 5, No. 3 1991, List 31). The World Health Organization schedules gadodiamide in its Anatomical Therapeutic Chemical (ATC) Classification. GADODIAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: [GD].OC(=O)CN(CCN(CC(=O)NC)CC(=O)O)CCN(CC(=O)NC)CC(=O)O.O. Most nations schedule Gadodiamide under HS 28469000.